skip to Main Content

Should PARP Inhibitors Have Tumor-Agnostic Approval Status?

Should PARP Inhibitors Have Tumor-Agnostic Approval Status?

Listen to Maurie Markman, MD discuss PARP inhibitors.

Watch here. . . 


Back To Top